Developer docs
API playgroundTry for free, no card

Search company profiles

Surgalign

Full company profile

uuid0005j9a

Namestring
Surgalign
Legal namestring
Surgalign Holdings, Inc.
Websiteurl
surgalign.com
Company typeenum
Public
Founded yearint
2020
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersDeerfield, United States
HQ citystring
Deerfield
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
surgical implants, spinal implants, orthobiologics products, digital surgical guidance, medical device manufacturing
Industry1 code
PRIMARYHLAHAEAC
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
NAICS code2 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
SIC code1 code
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
Product category
Spinal and Orthopedic Surgical Implants
Social media profiles1 record
Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Surgalign is a surgical implant company that supplies surgeons with safe biologic, metal, and synthetic implants used in spinal and orthopedic procedures. The company is also developing a digital surgical guidance system to complement its implant portfolio, following its acquisition of HoloSurgical Inc. in 2020.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Surgalign Holdings, Inc. is developing a digital surgical guidance system. The company announced a $50 million registered direct offering in June 2021 to support the development of this digital surgical guidance system and for working capital purposes. No further details about the product architecture, features, or modules are available in the provided source data.

Product and service1 record
1Biologic Surgical Implants
CategorySpinal and Orthopedic Surgical Implants
Description

Surgical implants made from biologic materials supplied by Surgalign to surgeons for use in spinal and orthopedic procedures.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Spine and orthobiologics company with parallel offering of spinal implant systems and biologic grafts; very similar end-customer and procedural footprint to Surgalign.

TypeBroad incumbent
Description

Diversified medtech incumbent with a large spine and biologics franchise; competes broadly with Surgalign across implant categories and has dominant surgeon relationships.

TypeDirect peer
Description

Spine-focused medical device company marketing cervical, thoracolumbar and interbody implants; competes with Surgalign for the same spine surgeon customers.

TypeDirect peer
Description

Mid-cap spine and biologics company offering spinal implants (cervical, pedicle screw, interbody) and orthobiologic grafts; very similar product mix and target customer to Surgalign.

TypeDirect peer
Description

Spine-only public company selling a similar portfolio of cervical, thoracolumbar and interbody implants; competes head-to-head with Surgalign's spine hardware franchise.

TypeDirect peer
Description

Long-standing direct competitor in spine surgery implants and minimally invasive techniques; overlapping customer base of spine surgeons and hospitals with comparable product breadth.

TypeBroad incumbent
Description

Large diversified orthopedic and surgical technologies player with spine hardware and surgical navigation offerings; overlapping capability but at much broader portfolio scale.

TypeDirect peer
Description

Spine-focused medical device company offering implants, biologics and enabling technologies including surgical robotics; directly competes with Surgalign in spine hardware and is rapidly expanding into digital guidance.

TypeDirect peer
Description

Spine and orthopedics player with biologics and spinal hardware products; competes with Surgalign in cervical and thoracolumbar fusion segments.

TypeBroad incumbent
Description

Global orthopedic leader with spine and surgical robotics (Rosa) platforms; competes with Surgalign across implants and is investing heavily in digital guidance technology.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Surgalign

Spinal and Orthopedic Surgical Implantssurgalign.com

Surgalign firmographics

Firmographics
Name
Surgalign
Legal name
Surgalign Holdings, Inc.
Website
https://surgalign.com
Company type
Public
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Surgalign industry classification

Industry
Product category
Spinal and Orthopedic Surgical Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
akta.pro industry
PRIMARYHLAHAEAC
Spine Implants & Motion Preservation (Fusion/Disc/Interspinous)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)

Keywords

  • Surgical implants
  • Spinal implants
  • Orthobiologics products
  • Digital surgical guidance
  • Medical device manufacturing

Where Surgalign is headquartered

Location

Headquarters

HQ city
Deerfield
HQ country
United States
HQ region
North America

Markets served

Surgalign business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Surgalign product offering

Product offering

Core offering

Surgalign is a surgical implant company that supplies surgeons with safe biologic, metal, and synthetic implants used in spinal and orthopedic procedures. The company is also developing a digital surgical guidance system to complement its implant portfolio, following its acquisition of HoloSurgical Inc. in 2020.

Product overview

Surgalign Holdings, Inc. is developing a digital surgical guidance system. The company announced a $50 million registered direct offering in June 2021 to support the development of this digital surgical guidance system and for working capital purposes. No further details about the product architecture, features, or modules are available in the provided source data.

Differentiator

Problem solved

Functional benefit

Products and services

  • Biologic Surgical Implants Surgical implants made from biologic materials supplied by Surgalign to surgeons for use in spinal and orthopedic procedures.

Companies that use Surgalign

Customer profile

Ideal customer profiles1 record

Surgalign technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Surgalign partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Surgalign competitors and assessment

Company assessment

Direct peers

  • SeaSpine: Spine and orthobiologics company with parallel offering of spinal implant systems and biologic grafts; very similar end-customer and procedural footprint to Surgalign.
  • Spinal Elements: Spine-focused medical device company marketing cervical, thoracolumbar and interbody implants; competes with Surgalign for the same spine surgeon customers.
  • Xtant Medical: Mid-cap spine and biologics company offering spinal implants (cervical, pedicle screw, interbody) and orthobiologic grafts; very similar product mix and target customer to Surgalign.
  • Alphatec Holdings: Spine-only public company selling a similar portfolio of cervical, thoracolumbar and interbody implants; competes head-to-head with Surgalign's spine hardware franchise.
  • NuVasive (now Globus Medical): Long-standing direct competitor in spine surgery implants and minimally invasive techniques; overlapping customer base of spine surgeons and hospitals with comparable product breadth.
  • Globus Medical: Spine-focused medical device company offering implants, biologics and enabling technologies including surgical robotics; directly competes with Surgalign in spine hardware and is rapidly expanding into digital guidance.
  • Orthofix Medical: Spine and orthopedics player with biologics and spinal hardware products; competes with Surgalign in cervical and thoracolumbar fusion segments.

Broad incumbents

  • Medtronic (Spine & Biologics): Diversified medtech incumbent with a large spine and biologics franchise; competes broadly with Surgalign across implant categories and has dominant surgeon relationships.
  • Stryker: Large diversified orthopedic and surgical technologies player with spine hardware and surgical navigation offerings; overlapping capability but at much broader portfolio scale.
  • Zimmer Biomet: Global orthopedic leader with spine and surgical robotics (Rosa) platforms; competes with Surgalign across implants and is investing heavily in digital guidance technology.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

Surgalign social profiles

Digital presence

Surgalign financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Surgalign leadership team

Management profile

Number of profiles

Profiles7 records

Surgalign funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Surgalign M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Surgalign

What does Surgalign do?

Surgalign is a surgical implant company that supplies surgeons with safe biologic, metal, and synthetic implants used in spinal and orthopedic procedures. The company is also developing a digital surgical guidance system to complement its implant portfolio, following its acquisition of HoloSurgical Inc. in 2020.

Is Surgalign a public or private company?

Surgalign is a public company. It is classified as public and is currently operating.

When was Surgalign founded?

Surgalign was founded in 2020. It employs 11 to 50 people.

Where is Surgalign based?

Surgalign is headquartered in Deerfield, United States, in the North America region.

Who are Surgalign's main competitors?

Direct peers on record are SeaSpine, Spinal Elements, Xtant Medical, Alphatec Holdings, NuVasive (now Globus Medical), Globus Medical and Orthofix Medical. Broad incumbents are Medtronic (Spine & Biologics), Stryker and Zimmer Biomet.

Does Surgalign have an API?

No public API is recorded for Surgalign.

What industry is Surgalign in?

Surgalign's product category is Spinal and Orthopedic Surgical Implants. Its primary akta.pro industry code is HLAHAEAC, Spine Implants & Motion Preservation (Fusion/Disc/Interspinous). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireU.S. Securities and Exchange Commission Establishes Surgalign Holdings, Inc. Fair FundThe SEC has established a Fair Fund for Surgalign Holdings, Inc. (formerly RTI Surgical Holdings, Inc.) to distribute $2,075,000 in civil money penalties to investors harmed by the company's undisclosed practice of shipping orders ahead of customer-requested delivery dates to meet quarterly revenue targets from 2015 through 2019. The company and its former CFO Robert Jordheim settled administrative proceedings in August 2022 without admitting or denying the findings. Eligible shareholders who purchased RTIX shares during the relevant period have until October 25, 2025, to submit claim forms through the appointed Fund Administrator Epiq Class Action & Claims Solutions, Inc.Ortho Spine NewsSports Medicine Market Global Forecast 2024-2030, Featuring Key Players Zimmer Biomet, Medtronic, Smith & Nephew, Stryker, Novartis, Johnson & Johnson, Conmed and Surgalign Holdings.The global sports medicine market is forecast to reach $10.34 billion by 2030, growing at a 6.04% CAGR from 2024 to 2030. The market was valued at $6.86 billion in 2023, driven by sports-related injuries and technological advances in orthopedic implants and minimally invasive surgery.MobiHealthNewsAugmedics buys assets of bankrupt Surgalign to grow spine surgery offeringsAugmedics purchased the digital health assets of bankrupt Surgalign and Holo Surgical for $900,000 to expand its spine surgery offerings. This acquisition adds Surgalign's AI-driven augmented reality guidance system to Augmedics' existing xvision platform, following the company's recent $82.5 million Series D funding round. The deal is part of a broader $5.9 million sale of Surgalign's total assets, with Xtant Medical Holdings acquiring the remaining hardware and biologics technology.Business Wire BlogAugmedics Strengthens AR/AI Portfolio With Planned Acquisition of Surgalign Digital Health AssetsAugmedics won a competitive auction for the digital health assets of Surgalign and Holo Surgical, strengthening its AR and AI portfolio. The sale will close pending bankruptcy court approval at a hearing set for August 8, 2023.GlobeNewswireDelisting of Securities of NantHealth, Inc.; Surgalign Holdings, Inc.; Lordstown Motors Corp.; iMedia Brands, Inc.; Crescera Capital Acquisition Corp.; Better World Acquisition Corp.; Tattooed Chef, INasdaq announced delisting of common stock for NantHealth, Surgalign, Lordstown Motors, iMedia Brands, Crescera Capital, Better World Acquisition, Tattooed Chef, and Alpine Summit Energy. Each company's securities were suspended between May 24 and July 21, 2023, and have not traded since.BenzingaShort Volatility Alert: Surgalign HoldingsOn June 23, 2023, shares of Surgalign Holdings (NASDAQ:SRGA) experienced volatile short activity, with the stock price rising 38.96% to $0.28. The securities lending volatility indicator showed a change of +114.26%, reaching 17.937, generating a bearish signal that triggered a "Strong Sell" recommendation. The volatility alert was produced by Tidal Markets in partnership with Benzinga Insights, which provides liquidity data to short sellers as an upstream market indicator.BenzingaSurgalign Files For Bankruptcy, Agrees To Sell Global Hardware & Biologics BusinessSurgalign Holdings Inc has filed for Chapter 11 bankruptcy and entered an asset purchase agreement to sell its hardware and biomaterials business to Xtant Medical Holdings Inc for $5 million. As part of its restructuring, Surgalign will reduce its workforce by about 25 employees and cut expenses by approximately $3.5 million over the next year. The company reported a decline in sales from $20.6 million to $16.7 million year-over-year and is dealing with significant operating losses.ReutersMedtech firm Surgalign files for Chapter 11 bankruptcySurgalign Holdings filed for voluntary Chapter 11 bankruptcy on Monday, with estimated assets and liabilities between $50 million and $100 million. The Deerfield, Illinois-based company had previously cut about 20% of its workforce and approved a restructuring plan in November.GlobeNewswireSurgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2022 ResultsSurgalign Holdings reported Q4 2022 revenue of $20.6 million, down from $21.8 million a year earlier, and an operating loss of $48.2 million. The company held $16.3 million in cash and expects $30-35 million in 2023 cash savings from its restructuring program.BioSpaceSurgalign Announces Release of HOLO™ AI Insights for Spine ImagingSurgalign announced the release of HOLO AI Insights, a cloud platform for automated analysis of lumbar spine MRI images, providing quantitative measurements of 16 anatomic structures. The insights are currently used for retrospective data analysis and are being deployed in research with the San Diego Spine Foundation. The company expects future applications in population health and patient care.